Table 4.
HHS network meta-analysis results.
| CD+BG | |||||
| -5.90 (-26.12, 14.27) | CD+PTRI | ||||
| -21.47 (-50.21, 7.35) | -15.57 (-50.73, 19.56) | CellTherapy | |||
| -16.06(-36.65, 4.39) | -10.16 (-38.99, 18.70) | 5.37 (-14.94, 25.73) | ESWT | ||
| -19.13 (-48.27, 9.94) | -13.25 (-48.47, 22.11) | 2.32(-26.62, 31.00) | -3.05(-23.58, 17.46) | ESWT+ Injectable med | |
| -14.62 (-46.76, 18.08) | -8.73 (-46.52, 29.73) | 6.86 (-25.23, 39.09) | 1.473 (-23.37, 26.79) | 4.51 (-9.47, 19.01) | Injectable med |
In the central diagonal, dark blue cells signify interventions. Cells below the interventions diagonal show efficacy: s.m.d. and 95% confidence intervals are reported. The yellow cells indicate the efficacy of intervention.